Tezepelumab reduced exacerbations across all seasons in severe uncontrolled asthma, even among patients with perennial and seasonal allergies.

Cannabis use is associated with a lower risk for alcohol-associated liver disease in patients with alcohol use disorder.

Risk factors for rheumatoid arthritis-related lung diseases include later RA onset, longer RA duration, and previous pulmonary infections.

For those with ALK+ NSCLC who received first-line, next-generation ALK TKI monotherapy, continuing ALK TKI with chemotherapy is linked to better outcomes.

The GOLD COPD Update 2026 provides updated guidance on case-finding, disease activity, exacerbation management.

In high-income areas, CV mortality generally declined in those with and without diabetes, but HF mortality reductions were smaller than atherosclerotic disease mortality.

Elexacaftor-tezacaftor-ivacaftor (ETI) may improve bronchial dilatations in adolescents with cystic fibrosis (CF).

Late-onset asthma risk is associated with numerous lifestyle-related metabolites, particularly among women, according to study findings published in The Journal of Allergy and Clinical Immunology.

Adding lactate trajectory classification into the SOFA score improved its accuracy in predicting mortality in sepsis-associated acute lung injury.

A rare bird flu virus has claimed the life of a Washington state resident, making it the first known human case of this specific strain in the US.

Peanut and IgE-mediated food allergy incidence in children significantly decreased since publication of early introduction guidelines in 2016.

For adults with VTE, continuing oral anticoagulants of at least 90 days is associated with a lower risk for recurrent VTE and a net clinical benefit.